Puma Biotechnology, Inc.PBYINASDAQ

Revenue (LTM)

$228M

-0.9% YoY

Net Income (LTM)

$31M

+2.8% YoY

Free Cash Flow

$42M

Revenue CAGR (5Y)

-2.5%

Marginsdeclining

FCF$0.0B

Profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	253	228↓9.9%	236↑3.3%	230↓2.2%	228↓0.9%
Gross Profit	189	173↓8.7%	173↑0.0%	166↓4.0%	170↑2.5%
Operating Income	1	24↑1738.8%	33↑37.6%	31↓5.1%	37↑20.5%
Net Income	-29	0↑100.0%	22↑1079450.0%	30↑40.2%	31↑2.8%
EBITDA	-5	22↑566.7%	48↑117.1%	48↑1.2%	53↑11.0%
EPS Diluted	-0.72	0.02↑102.8%	0.45↑2116.7%	0.62↑37.8%	0.61↓1.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	63	76↑20.7%	85↑11.0%	69↓18.2%	30↓57.2%
Total Current Assets	140	134↓4.1%	156↑16.3%	148↓5.5%	163↑10.2%
Total Assets	227	222↓2.0%	231↑3.8%	213↓7.5%	216↑1.4%
Total Current Liabilities	110	77↓29.3%	99↑28.3%	96↓3.3%	81↓15.5%
Total Liabilities	229	200↓12.5%	177↓11.7%	121↓31.6%	86↓29.1%
Total Equity	-2	22↑983.4%	53↑147.3%	92↑72.4%	130↑41.5%
Total Debt	117	114↓2.0%	111↓2.4%	74↓33.6%	29↓61.5%
Net Debt	54	38↓28.8%	27↓29.3%	5↓81.9%	-1↓122.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	21	-16↓176.6%	27↑270.7%	39↑44.1%	42↑7.4%
Capital Expenditure	0	-7	-13↓80.6%	-0↑99.6%	-0↓26.8%
Free Cash Flow	21	-23↓210.5%	14↑162.9%	39↑170.5%	42↑7.4%
Stock-Based Comp	33	12↓63.8%	10↓13.4%	8↓19.5%	7↓15.8%
Net Change in Cash	-22	4↑115.8%	8↑125.3%	-15↓294.9%	-40↓157.6%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance